Breathing Control in Patients With Chronic Obstructive Pulmonary Disease (COPD)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01512043 |
Recruitment Status
:
Completed
First Posted
: January 19, 2012
Last Update Posted
: May 6, 2014
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
COPD | Behavioral: Breathing control | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 150 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Participant, Investigator) |
Official Title: | Breathing Control in Patients With Chronic Obstructive Pulmonary Disease (COPD) Intervention With Device-guided Breathing Control in COPD |
Study Start Date : | July 2011 |
Actual Primary Completion Date : | September 2013 |
Actual Study Completion Date : | September 2013 |
Arm | Intervention/treatment |
---|---|
Experimental: 1. Breathing control
Description ...
|
Behavioral: Breathing control
Practice of device guided breathing control twice a day for four weeks.
|
Active Comparator: 2. Listening to music
Listening to music without guiding on breathing on the same device as breathing control twice a day for four weeks. Using the device to measure breathing movements.
|
Behavioral: Breathing control
Practice of device guided breathing control twice a day for four weeks.
|
Sham Comparator: 3. Silence
Using the device to measure breathing movement twice a day for four weeks. No instruction on breathing control and no music.
|
Behavioral: Breathing control
Practice of device guided breathing control twice a day for four weeks.
|
- Breathlessness [ Time Frame: 4 months ]Questionnaires
- Depression [ Time Frame: 4 months ]Questionnaires
- Pulmonary functional tests [ Time Frame: 4 months ]
- Anxiety [ Time Frame: 4 months ]Questionnaires
- Fatigue [ Time Frame: 4 months ]Questionnaire
- Sleeping difficulties [ Time Frame: 4 months ]Questionnaires
- Pain [ Time Frame: 4 months ]Questionnaire
- 6. Min walk test [ Time Frame: 4 months ]
- Arterial blood gas measures [ Time Frame: 4 months ]
- Quality of life [ Time Frame: 4 months ]Questionnaire

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 30 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Dyspnoea symptoms in daily life
- Spirometry values showing a COPD moderate stage II (FEV1/FVC<70%, FEV1<80%) and severity grade at a severe stage III (FEV1/FVC<70%, FEV1<50% and FEV1 = 30% of a predicted)
- Be able to read, write and speak Norwegian
- Be at a stable phase of the disease
Exclusion Criteria:
- Changes in pulmonary medication during the last 4 weeks
- Diagnosis of cancer
- Presently attending a pulmonary rehabilitation course or other similar COPD education courses (due to the fact that these courses often have instructions on breathing control), or having attended similar courses during the last six months
- Ongoing exacerbation
- Attending other competitive studies
- Diagnosis of neuromuscular disease
- Diagnosis of dementia
- Attending help from a pulmonary physiotherapist

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01512043
Norway | |
Lovisenberg Diakonale Hospital | |
Oslo, Norway, 0440 |
Principal Investigator: | Astrid K Wahl, Professor | University of Oslo |
Responsible Party: | Lovisenberg Diakonale Hospital |
ClinicalTrials.gov Identifier: | NCT01512043 History of Changes |
Other Study ID Numbers: |
2009/2/0285 |
First Posted: | January 19, 2012 Key Record Dates |
Last Update Posted: | May 6, 2014 |
Last Verified: | May 2014 |
Keywords provided by Lovisenberg Diakonale Hospital:
Breathlessness Symptoms Quality of life |
Additional relevant MeSH terms:
Lung Diseases Lung Diseases, Obstructive Pulmonary Disease, Chronic Obstructive Respiratory Tract Diseases |